Cerevel Therapeutics’ Parkinson’s disease therapy tavapadon has shown efficacy in a phase 3 trial, reinforcing its blockbuster potential and no doubt delighting AbbVie, which has agreed to buy the ...
US FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve The U.S. Federal Trade Commission won a ruling on Friday blocking Edwards Lifesciences' acquisition of JenaValve Technology, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback